JIN Nan, MAO Yue, TANG Xudong. Thoughts and methods of differentiation and treatment of senile high-risk myelodysplastic syndrome[J]. Modern Chinese Clinical Medicine, 2022,29(5):35-38.
JIN Nan, MAO Yue, TANG Xudong. Thoughts and methods of differentiation and treatment of senile high-risk myelodysplastic syndrome[J]. Modern Chinese Clinical Medicine, 2022,29(5):35-38. DOI: 10.3969/j.issn.2095-6606.2022.05.008.
Myelodysplastic syndrome (MDS) is a malignant clonal disease of acquired hematopoietic stem cells. According to the symptoms of high-risk MDS in the elderly
it belongs to the category of
suǐ dú láo
(marrow poisoning and fatigue) in traditional Chinese medicine. Its etiology and pathogenesis are based on deficiency of the spleen and kidney
coupled with blood stasis and other pathogenic factors. Clinical principle of syndrome differentiation and treatment: detoxification and removing blood stasis as the core
tonifying spleen and kidney as the foundation; the approach of regulating and tonifying the spleen and stomach
and soothing liver and regulating qi is also emphasized. The combined use of cold and heat medicinals is key in the treatment
and special attention is given to maintaining the yin and yang balance. This paper summarizes the experience of diagnosis and treatment of elderly high-risk MDS based on clinical case records.
关键词
骨髓增生异常综合征髓毒劳补肾健脾青黄散
Keywords
myelodysplastic syndromemarrow poisoning and fatiguetonifying the kidney and invigorating the spleenQinghuang Powder
references
周剑锋,孙汉英,张义成.血液病诊疗指南[M].3版.北京:科学出版社,2013: 131.
ROLLISON D E,HOWLADER N,SMITH M T,et al.Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States,2001-2004,using data from the NAACCR and SEER programs[J].Blood,2008, 112(1): 45-52.